Literature DB >> 12554904

Pharmacotherapy and airway remodelling in asthma?

P A Beckett1, P H Howarth.   

Abstract

Over the last few decades attention has largely focused on airway inflammation in asthma, but more recently it has been appreciated that there are important structural airway changes which have been grouped together under the term "airway remodelling". It is only now that questions have been asked about the impact of treatment on these structural changes. This review examines the nature of these structural airway changes, the mechanisms of their generation, their potential consequences, and what is known about the ability of anti-asthma treatments to modulate these changes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12554904      PMCID: PMC1746582          DOI: 10.1136/thorax.58.2.163

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  173 in total

Review 1.  Efficacy and safety of inhaled corticosteroids. New developments.

Authors:  P J Barnes; S Pedersen; W W Busse
Journal:  Am J Respir Crit Care Med       Date:  1998-03       Impact factor: 21.405

2.  On the mechanism of mucosal folding in normal and asthmatic airways.

Authors:  B R Wiggs; C A Hrousis; J M Drazen; R D Kamm
Journal:  J Appl Physiol (1985)       Date:  1997-12

3.  Pulmonary function during clinical remission of asthma. How reversible is asthma?

Authors:  J F Cade; M C Pain
Journal:  Aust N Z J Med       Date:  1973-12

4.  Glucocorticoid-mediated selective reduction of functioning collagen messenger ribonucleic acid.

Authors:  R J Rokowski; J Sheehy; K R Cutroneo
Journal:  Arch Biochem Biophys       Date:  1981-08       Impact factor: 4.013

5.  In vitro inhibition of cell growth, collagen synthesis, and prolyl hydroxylase activity by triamcinolone acetonide.

Authors:  B J McCoy; R F Diegelmann; I K Cohen
Journal:  Proc Soc Exp Biol Med       Date:  1980-02

6.  Switching of the coupling of the beta2-adrenergic receptor to different G proteins by protein kinase A.

Authors:  Y Daaka; L M Luttrell; R J Lefkowitz
Journal:  Nature       Date:  1997-11-06       Impact factor: 49.962

7.  Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

Authors:  R A Pauwels; C G Löfdahl; D S Postma; A E Tattersfield; P O'Byrne; P J Barnes; A Ullman
Journal:  N Engl J Med       Date:  1997-11-13       Impact factor: 91.245

8.  Reversal of human lymphocyte beta-adrenoceptor desensitization by glucocorticoids.

Authors:  K K Hui; M E Conolly; D P Tashkin
Journal:  Clin Pharmacol Ther       Date:  1982-11       Impact factor: 6.875

9.  Airways obstruction in patients with long-term asthma consistent with 'irreversible asthma'.

Authors:  K S Backman; P A Greenberger; R Patterson
Journal:  Chest       Date:  1997-11-05       Impact factor: 9.410

10.  Effects of corticosteroids on the proliferation of normal and abnormal human connective tissue cells.

Authors:  G C Priestley; J C Brown
Journal:  Br J Dermatol       Date:  1980-01       Impact factor: 9.302

View more
  22 in total

Review 1.  Clinical assessment of airway remodeling in asthma: utility of computed tomography.

Authors:  Akio Niimi; Hisako Matsumoto; Masaya Takemura; Tetsuya Ueda; Yasutaka Nakano; Michiaki Mishima
Journal:  Clin Rev Allergy Immunol       Date:  2004-08       Impact factor: 8.667

2.  Inhaled corticosteroids and decline of lung function in community residents with asthma.

Authors:  P Lange; H Scharling; C S Ulrik; J Vestbo
Journal:  Thorax       Date:  2006-02       Impact factor: 9.139

3.  Inhaled corticosteroids moderate lung function decline in adults with asthma.

Authors:  P Ernst
Journal:  Thorax       Date:  2006-02       Impact factor: 9.139

4.  A randomized clinical trial of peak flow versus symptom monitoring in older adults with asthma.

Authors:  A Sonia Buist; William M Vollmer; Sandra R Wilson; E Ann Frazier; Arthur D Hayward
Journal:  Am J Respir Crit Care Med       Date:  2006-08-24       Impact factor: 21.405

Review 5.  Airway remodeling: a potential therapeutic target in asthma.

Authors:  Wei-Xi Zhang; Chang-Chong Li
Journal:  World J Pediatr       Date:  2011-05-15       Impact factor: 2.764

6.  Role of hyaluronan and hyaluronan-binding proteins in human asthma.

Authors:  Jiurong Liang; Dianhua Jiang; Yoosun Jung; Ting Xie; Jennifer Ingram; Tony Church; Simone Degan; Maura Leonard; Monica Kraft; Paul W Noble
Journal:  J Allergy Clin Immunol       Date:  2011-05-13       Impact factor: 10.793

7.  Eosinophils and CCR3 regulate interleukin-13 transgene-induced pulmonary remodeling.

Authors:  Patricia C Fulkerson; Christine A Fischetti; Marc E Rothenberg
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

8.  Corticosteroid administration reduces the concentration of hyaluronan in bronchoalveolar lavage in a murine model of eosinophilic airway inflammation.

Authors:  Glenda Ernst; Silvina Lompardía; Rosalía Cordo Russo; Virginia Gentilini; Stella Venturiello; Fernando Galíndez; Pedro Grynblat; Silvia E Hajos
Journal:  Inflamm Res       Date:  2012-07-28       Impact factor: 4.575

9.  High-resolution computed tomography evaluation of airway distensibility in asthmatic and healthy subjects.

Authors:  A Castagnaro; A Rastelli; A Chetta; E Marangio; P Tzani; M De Filippo; M Aiello; R D'Ippolito; D Olivieri; N Sverzellati; M Zompatori
Journal:  Radiol Med       Date:  2008-02-25       Impact factor: 3.469

10.  The Variants in the 3' Untranslated Region of the Matrix Metalloproteinase 9 Gene as Modulators of Treatment Outcome in Children with Asthma.

Authors:  Sandra Dragicevic; Mitja Kosnik; Aleksandra Divac Rankov; Matija Rijavec; Katarina Milosevic; Peter Korosec; Maja Skerbinjek Kavalar; Aleksandra Nikolic
Journal:  Lung       Date:  2018-03-29       Impact factor: 2.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.